Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB. 1.5, XBB. 1.16 and EG. 5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA. 4/5 Bivalent …

RRG Machado, ÉD Candido, AS Aguiar, VN Chalup… - Vaccines, 2024 - mdpi.com
The recently emerged SARS-CoV-2 Omicron sublineages, including the BA. 2-derived XBB.
1.5 (Kraken), XBB. 1.16 (Arcturus), and EG. 5.1 (Eris), have accumulated several spike …

Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA. 1, BA. 2, and BA. 4/5 Variants

M Jäger, G Diem, S Sahanic, V Fux… - The Journal of …, 2023 - academic.oup.com
Background The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variants BA. 1, BA. 2, and BA. 4/5 demonstrate higher transmission and infection …

BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA. 1 in …

A Seidel, M Zanoni, R Groß, D Krnavek… - Frontiers in …, 2022 - frontiersin.org
In light of the decreasing immune protection against symptomatic SARS-CoV-2 infection
after initial vaccinations and the now dominant immune-evasive Omicron variants,'booster' …

[HTML][HTML] Distinct neutralizing antibody escape of SARS-CoV-2 Omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7 and BA. 2.75. 2

P Qu, JP Evans, J Faraone, YM Zheng, C Carlin… - Biorxiv, 2022 - ncbi.nlm.nih.gov
Continued evolution of SARS-CoV-2 has led to the emergence of several new Omicron
subvariants, including BQ. 1, BQ. 1.1, BA. 4.6, BF. 7 and BA. 2.75. 2. Here we examine the …

[PDF][PDF] Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2

P Qu, JP Evans, JN Faraone, YM Zheng, C Carlin… - Cell host & …, 2023 - cell.com
The continued evolution of SARS-CoV-2 has led to the emergence of several new Omicron
subvariants, including BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2. Here, we examine the …

Breakthrough SARS-CoV-2 Omicron variant in individuals primed with heterologous vaccines enhances inhibition performance of neutralizing antibody to BA. 2 …

J Szekely, P Swangphon, N Nanakorn, P Chaimuti… - Vaccines, 2023 - mdpi.com
This study aims to analyze the neutralization ability against Omicron parental variants in five
clusters of individuals with different Coronavirus disease (COVID-19) immunity …

Neutralization of SARS-CoV-2 BQ. 1.1 and XBB. 1.5 by breakthrough infection sera from previous and current waves in China

X Wang, S Jiang, S Jiang, X Li, J Ai, K Lin, S Lv… - bioRxiv, 2023 - biorxiv.org
SARS-CoV-2 is continuing to evolve and diversify, with an array of various Omicron sub-
lineages, including BA. 5, BA. 2.75, BN. 1, BF. 7, BQ. 1, BQ. 1.1, XBB and XBB. 1.5, now …

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA. 1 infection

C Kurhade, J Zou, H Xia, M Liu, Q Yang… - Emerging Microbes & …, 2022 - Taylor & Francis
ABSTRACT Distinct SARS-CoV-2 Omicron sublineages have evolved showing increased
fitness and immune evasion than the original Omicron variant BA. 1. Here, we report the …

Neutralisation of SARS-CoV-2 Omicron subvariants BA. 2.86 and EG. 5.1 by antibodies induced by earlier infection or vaccination

R Lassauniere, C Polacek, S Baig, K Ellegaard… - Biorxiv, 2023 - biorxiv.org
Highly mutated SARS-CoV-2 Omicron subvariant BA. 2.86 emerged in July 2023. We
investigated the neutralisation of isolated virus by antibodies induced by earlier infection or …

Different neutralization profiles after primary SARS-CoV-2 Omicron BA. 1 and BA. 2 infections

I Medits, DN Springer, M Graninger, JV Camp… - Frontiers in …, 2022 - frontiersin.org
Background and Methods The SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) Omicron (B. 1.1. 529) variant is the antigenically most distinct variant to date …